Funding for this research was provided by:
PetBIOMICS Ltd
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 14 October 2020
Accepted: 20 May 2021
First Online: 2 June 2021
Declarations
:
: Claudia Ottka is a current employee and Hannes Lohi the board director of PetBIOMICS – a start-up company providing NMR metabolomic testing for dogs. Elisabeth Müller is the managing director and Corinna Weber the head of department of LABOKLIN – an animal diagnostic laboratory.
: All used samples were leftovers of clinical samples, collected for the benefit of the patient.
: Consent for the scientific use of leftover canine sample material was obtained for all samples during sample submission.
: The study does not include any personal data or photographs of human subjects.